About ginealach
This author has not written his bio yet.
But we are proud to say that ginealach contributed 75 entries already.
Entries by ginealach
AACR Annual Meeting 2022
AACR Annual Meeting 2022 New Orleans, 8-13 April 2022
2nd TPD Europe Summit
2nd TPD Europe Summit (tpd-europe.com) 15-17 March 2022
Amphista Therapeutics Appoints Dr Martin Pass as CDO
Cambridge, England, 6 December 2021 – Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the appointment of Dr Martin Pass, as Chief Development Officer (CDO). Martin joins Amphista from AstraZeneca, where he was Vice President, Head Early Oncology Projects and led successful clinical development efforts. Martin has over 30 […]
Amphista Therapeutics Appoints CBO, Beverley Carr
Cambridge, England, 1 November 2021 – Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the appointment of a Chief Business Officer (CBO), Beverley Carr. Amphista’s CEO Dr Nicola Thompson said, “On behalf of the Amphista team, I am thrilled to welcome Beverley as our CBO. Beverley brings a wealth […]
Amphista Therapeutics Appoints New Chairman, Joshua T. Brumm
Glasgow, UK, 21 September 2021 – Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the appointment of Joshua T. Brumm as its new Independent Chairman, succeeding Satish Jindal. Amphista’s CEO Dr Nicola Thompson said, “On behalf of the Amphista team I am thrilled to welcome someone of Josh’s calibre […]
Bio21
Bio21 14 June 2021 – 18 June 2021
Annual Drug Design and Medicinal Chemistry Congress, London
Annual Drug Design and Medicinal Chemistry Congress, London 01 June 2021 – 02 June 2021
BioEquity Europe Digital
BioEquity Europe Digital 17 May 2021 – 19 May 2021
BIO-Europe Spring
BIO-Europe Spring 22 March 2021 – 25 March 2021